Guillain-Barré syndrome after SARS-CoV-2 infection
- PMID: 34518789
- PMCID: PMC8426991
- DOI: 10.1002/jgf2.481
Guillain-Barré syndrome after SARS-CoV-2 infection
Abstract
We herein report a case of Guillain-Barré syndrome (GBS) after SARS-CoV-2 infection. The patient was a close contact with a SARS-CoV-2 patient. Initially, she did not have any symptoms and quarantined at a hotel. Dysgeusia and olfactory abnormality appeared at day 6 after testing positive for infection and disappeared by day 9. Subsequently, the patient developed numbness of the arms and legs, difficulty walking, and dyspnea and was referred to our hospital. Her clinical examination showed generalized weakness and hyporeflexia. A cerebrospinal fluid analysis showed albuminocytological dissociation. Her nerve conduction studies were consistent with demyelinating polyneuropathy. Intravenous immunoglobulin was administered based on a diagnosis of GBS.
Keywords: COVID‐19; Guillain‐Barré syndrome; SARS‐CoV‐2; coronavirus disease 2019; demyelinating polyneuropathy; severe acute respiratory syndrome coronavirus 2.
© 2021 The Authors. Journal of General and Family Medicine published by John Wiley & Sons Australia, Ltd on behalf of Japan Primary Care Association.
Conflict of interest statement
The authors have stated explicitly that there are no conflicts of interest in connection with this article.
References
-
- Coronavirus Resource Center ‐ Johns Hopkins University. https://coronavirus.jhu.edu. Accessed 21 June 2021.
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous